Biotech / Medtech Archives | citybizSciencenews

Arrakis Therapeutics Names Mark DeLong CEO Ahead of Clinical-Stage Transition

Thursday, June 25, 2026Win WarfieldView original

Arrakis Therapeutics has appointed biotech executive Mark DeLong as chief executive officer, effective June 29, 2026, as the company prepares... Read More

The post Arrakis Therapeutics Names Mark DeLong CEO Ahead of Clinical-Stage Transition appeared first on citybiz.